tacrine has been researched along with apigenin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fernández-Bachiller, MI; Monjas, L; Pérez, C; Rademann, J; Rodríguez-Franco, MI | 1 |
| Baek, SC; Cho, ML; Kang, MG; Kim, H; Lee, H; Lee, JP; Oh, SR; Park, CM; Park, D; Park, JE; Ryu, HW | 1 |
| Dolezal, R; Hrabinova, M; Janockova, J; Jost, P; Jun, D; Kaping, D; Korabecny, J; Kuca, K; Kucera, T; Mezeiova, E; Muckova, L; Sepsova, V; Soukup, O; Spilovska, K | 1 |
3 other study(ies) available for tacrine and apigenin
| Article | Year |
|---|---|
New tacrine-4-oxo-4H-chromene hybrids as multifunctional agents for the treatment of Alzheimer's disease, with cholinergic, antioxidant, and β-amyloid-reducing properties.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Animals; Antioxidants; Aspartic Acid Endopeptidases; Benzopyrans; Blood-Brain Barrier; Butyrylcholinesterase; Catalytic Domain; Cattle; Cholinesterase Inhibitors; Chromones; Free Radical Scavengers; Humans; Membranes, Artificial; Permeability; Structure-Activity Relationship; Tacrine | 2012 |
Osthenol, a prenylated coumarin, as a monoamine oxidase A inhibitor with high selectivity.
Topics: Acetylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Coumarins; Enzyme Assays; Humans; Kinetics; Molecular Docking Simulation; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Protein Binding; Structure-Activity Relationship | 2019 |
Novel Tacrine-Scutellarin Hybrids as Multipotent Anti-Alzheimer's Agents: Design, Synthesis and Biological Evaluation.
Topics: Acetylcholinesterase; Alzheimer Disease; Apigenin; Blood-Brain Barrier; Butyrylcholinesterase; Cholinesterase Inhibitors; Drug Design; Enzyme Activation; Glucuronates; Humans; Molecular Docking Simulation; Structure-Activity Relationship; Tacrine | 2017 |